A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer

A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer

IntroductionWe performed this clinical trial to evaluate the efficacy and safety of apatinib and oral etoposide in patients with HER2-negative locally advanced or metastatic breast cancer (MBC).MethodsPatients with HER2-negative MBC previously treated with anthracycline and taxanes and failed ≥1 pri...

Full description

Bibliographic Details
Main Authors: Nanlin Hu, Anjie Zhu, Yiran Si, Jian Yue, Xue Wang, Jiayu Wang, Fei Ma, Binghe Xu, Peng Yuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
apatinib
breast cancer
angiogenesis
HER2-negative
oral etoposide
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.565384/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.565384/full

Similar Items